Use of Epinastine for the treatment of pain

US5942503A · kind A · utility

Assignee

• Boehringer Indelheim KG · DE

Inventors

• Birgit Jung · Laupheim, DE
• Christopher Meade · Bingen, DE
• Michel Pairet · Biberach, DE

Key dates

• Filing date: Jun 9, 1998
• Grant date: Aug 24, 1999
• Expiry date: Jun 9, 2018

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein is the use of epinastine for the treatment of pain, including migraine, Bing-Horton syndrome, tension headaches, muscle pain, inflammatory pain, and neuralgias. Epinastine may also be administered in combination with an additional analgesic for treating pain.